SILVER SPRING, Md., Nov. 16, 2020 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous ...
Doctors treated eight-year-old Dixie's tumor with Stelfonta, a drug derived from a plant in the Australian rainforest Digital News Writer, PEOPLE A Georgia family is paw-sitively over the moon after ...
Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs). The FDA is also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback